Skip to content

EFFECTS OF ADJUVANT NEUROSTIMULATION (THETA BURTS STIMULATION) ON FACIAL EMOTIONAL RECOGNITION IN PATIENTS OF SCHIZOPHRENIA: AfMRI STUDY

ADJUVANT cTBS ON FACIAL EMOTIONAL RECOGNITION IN PATIENTS OF SCHIZOPHRENIA; A fMRI STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050943
Enrollment
30
Registered
2023-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: adjuvant continuos theta burst stimulation ,active: 10 sessions over 2 weeks over right ventromedial pre frontal cortex via double cone coil in active group.ctbs - bursts of 3 pulses of

Sponsors

CENTRAL INSTITUTE OF PSYCHIATRY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients giving written informed consent. 2. Right handed. 3. Age between 18- 60 years of either sex. 4. Illness duration of equal to or more than 2 years. 5. Diagnosis of Schizophrenia using Diagnostic Criteria for Research (DCR) of International Classification of Disease-10th edition (ICD-10, World Health Organization,1993) . 6. The Positive and Negative Syndrome Scale for Schizophrenia (PANSS),negative symptoms score of more than 15. 7. Scale for Assessment of Negative Symptoms (SANS) score more than 20. 8. Calgary Depression Scale for Schizophrenia (CDSS) score less than 7. 9. Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham,1962) to assess symptoms in schizophrenia.

Exclusion criteria

Exclusion criteria: 1. Presence of co-morbid neurological or other psychiatric disorder(s). 2. Patient with co-morbid substance dependence, except nicotine and caffeine. 3. Subjects who have received ECT in past 6 months. 4. Patients having any metallic implants/parts in the body. 5. Not willing to give informed consent.

Design outcomes

Primary

MeasureTime frame
functional connectivityTimepoint: baseline and at the end of sessions

Secondary

MeasureTime frame
PANSS,SANS,BPRS,MDEESTimepoint: baseline and at the end of sessions

Countries

India

Contacts

Public ContactDr SUNILKUMAR SURYAVANSHI

CENTRAL INSTITUTE OF PSYCHIATRY

sunilsuryavanshi5@gmail.com8007774822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026